首页> 外文期刊>Current Eye Research >Microbiological Isolates and Antibiotic Susceptibilities: A 10-Year Review of Culture-Proven Endophthalmitis Cases
【24h】

Microbiological Isolates and Antibiotic Susceptibilities: A 10-Year Review of Culture-Proven Endophthalmitis Cases

机译:微生物分离株和抗生素敏感性:对文化的内心炎病例的10年综述

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To review the microbiological spectrum and antibiotic sensitivities of the pathogens that cause culture-proven endophthalmitis and to understand the status and trends of antibiotic susceptibility at a public hospital over a 10-year period.Methods: The data of 577 culture-proven endophthalmitis isolates collected between April 2004 and April 2014 were reviewed retrospectively. The antibiotic sensitivities were determined according to the criteria of the Clinical and Laboratory Standards Institute. The changes in antibiotic susceptibility over the 10 years were subjected to (2) tests for trends.Results: Among these isolates, 65% were gram-positive organisms (375), 16.6% were gram-negative organisms (96), and 18.4% were fungi (106).The predominant pathogens were Staphylococcal species (Staphylococcus epidermidis in 175, other coagulase-negative Staphylococci in 41, and Staphylococcus aureus in 54 cases), followed by Bacillus cereus isolates. The Aspergillus species was the most frequently isolated fungus, and Pseudomonas aeruginosa was the most frequently isolated gram-negative bacteria. The antibiotic susceptibilities of gram-positive bacteria were as follows: vancomycin, 97.6%; levofloxacin, 85.1%; gentamicin, 78.7%; rifampin, 77.2%; ofloxacin, 77.2%; chloramphenicol, 76.4%; and ciprofloxacin, 73.7%. The antibiotic susceptibilities of gram-negative isolates were as follows: ceftazidime, 50.5%; ciprofloxacin, 82.2%; amikacin, 81.3%; tobramycin, 80.2%; imipenem, 79.7%; and gentamicin, 78%. Over the 10-year study, there were significant changes in the antibiotic susceptibilities to the following five antibiotics: vancomycin, imipenem, penicillin G, amikacin, and trimethoprim-sulfamethoxazole (TMP-SMX).Conclusions: Vancomycin remains the most appropriate empirical antibiotic for gram-positive bacteria. The susceptibilities of the gram-negative organisms to ciprofloxacin and amikacin were greater than that to ceftazidime. Trends toward increases in the susceptibilities to the following five antibiotics were observed: vancomycin, imipenem, penicillin G, amikacin, and TMP-SMX.
机译:目的:审查病原体的微生物谱和抗生素敏感性,导致培养培养的内膜炎,并在10年期间了解公共医院的抗生素易感性的现状和趋势。方法:577种文化的内膜炎的数据回顾性地审查了2004年4月至2014年4月至2014年4月期间收集的孤立。根据临床和实验室标准研究所的标准确定抗生素敏感性。 10年内抗生素易感性的变化受到(2)趋势的试验。结果:这些分离物中,65%是革兰氏阳性生物(375),16.6%是革兰氏阴性生物(96),18.4%是真菌(106)。主要病原体是葡萄球菌(175中的金葡萄球菌,其它凝血酶阴性葡萄球菌在41中,54例中的金黄色葡萄球菌),其次是芽孢杆菌分离株。曲霉属物种是最常分离的真菌,假单胞菌铜绿假单胞菌是最常见的革兰氏阴性细菌。革兰氏阳性细菌的抗生素敏感性如下:万古霉素,97.6%;左氧氟沙星,85.1%;庆大霉素,78.7%;利福平,77.2%;氧氟沙星,77.2%;氯霉素,76.4%;和环丙沙星,73.7%。革兰氏阴性分离物的抗生素敏感性如下:头孢他啶,50.5%;环丙沙星,82.2%; Amikacin,81.3%;杂草霉素,80.2%; Imipenem,79.7%;和庆大霉素,78%。在10年的研究中,抗生素敏感性的显着变化对以下五种抗生素:万古霉素,亚胺尼,青霉素G,Amikacin和Trimethorlim-磺胺甲氧唑(TMP-SMX)。结论:万古霉素仍然是最合适的经验抗生素革兰氏阳性细菌。革兰氏阴性生物对环丙沙星和阿米卡星的敏感性大于头孢他啶。观察到对敏感性增加的趋势增加了以下五种抗生素:万古霉素,亚胺尼,青霉素G,Amikacin和TMP-SMX。

著录项

  • 来源
    《Current Eye Research》 |2017年第3期|共5页
  • 作者单位

    Fudan Univ Shanghai Med Coll Eye Ear Nose &

    Throat ENT Hosp Dept Lab Med 83 Fenyang Rd;

    Fudan Univ Shanghai Med Coll Eye Ear Nose &

    Throat ENT Hosp Dept Lab Med 83 Fenyang Rd;

    Fudan Univ Shanghai Med Coll Eye Ear Nose &

    Throat ENT Hosp Dept Lab Med 83 Fenyang Rd;

    Fudan Univ Shanghai Med Coll Eye Ear Nose &

    Throat ENT Hosp Dept Lab Med 83 Fenyang Rd;

    Fudan Univ Shanghai Med Coll Eye Ear Nose &

    Throat ENT Hosp Dept Lab Med 83 Fenyang Rd;

    Fudan Univ Shanghai Med Coll Eye Ear Nose &

    Throat ENT Hosp Dept Lab Med 83 Fenyang Rd;

    Fudan Univ Shanghai Med Coll Eye Ear Nose &

    Throat ENT Hosp Dept Ophthalmol &

    Visual Sci 83;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 眼科学;
  • 关键词

    Microbiological isolates; antibiotic susceptibility; endophthalmitis; ceftazidim; ciprofloxacin;

    机译:微生物分离株;抗生素易感性;眼球炎;Ceftazidim;CiProfloxacin;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号